000 | 01813 a2200517 4500 | ||
---|---|---|---|
005 | 20250517051329.0 | ||
264 | 0 | _c20160719 | |
008 | 201607s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.4422 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHo, Chun-Te | |
245 | 0 | 0 |
_aFolate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma. _h[electronic resource] |
260 |
_bOncotarget _cSep 2015 |
||
300 |
_a26104-18 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xgenetics |
650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCulture Media _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aEndoplasmic Reticulum Chaperone BiP |
650 | 0 | 4 |
_aFolic Acid _xmetabolism |
650 | 0 | 4 |
_aHeat-Shock Proteins _xgenetics |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xgenetics |
650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSurvivin |
700 | 1 | _aShang, Hung-Sheng | |
700 | 1 | _aChang, Jin-Biou | |
700 | 1 | _aLiu, Jun-Jen | |
700 | 1 | _aLiu, Tsan-Zon | |
773 | 0 |
_tOncotarget _gvol. 6 _gno. 28 _gp. 26104-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.4422 _zAvailable from publisher's website |
999 |
_c25219785 _d25219785 |